Globus Medical, Inc.

NYSE GMED

Globus Medical, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 54.53%

Globus Medical, Inc. Gross Profit Margin is 54.53% for the Trailing 12 Months (TTM) ending September 30, 2024, a -23.41% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Globus Medical, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 71.19%, a -4.39% change year over year.
  • Globus Medical, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 74.47%, a -0.30% change year over year.
  • Globus Medical, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 74.69%, a 1.99% change year over year.
  • Globus Medical, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 73.23%, a -4.87% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
NYSE: GMED

Globus Medical, Inc.

CEO Mr. Daniel T. Scavilla
IPO Date Aug. 3, 2012
Location United States
Headquarters 2560 General Armistead Avenue
Employees 5,000
Sector Health Care
Industries
Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Similar companies

PODD

Insulet Corporation

USD 267.04

-0.35%

BRKR

Bruker Corporation

USD 61.26

-2.69%

INSP

Inspire Medical Systems, Inc.

USD 169.99

-3.10%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

NVRO

Nevro Corp.

USD 3.70

-8.19%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

NARI

Inari Medical, Inc.

USD 79.30

-0.05%

ATEC

Alphatec Holdings, Inc.

USD 11.12

2.21%

NVCR

NovoCure Limited

USD 26.23

-4.20%

IRTC

iRhythm Technologies, Inc.

USD 99.01

4.67%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email